Inspire Medical Systems, Inc. to Present at 43rd Annual J.P. Morgan Healthcare Conference
Inspire Medical Systems, Inc. to Present at 43rd Annual J.P. Morgan Healthcare Conference
MINNEAPOLIS, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025.
明尼阿波利斯，2024年12月30日（環球新聞社）——Inspire Medical Systems, Inc.（紐交所：INSP）（Inspire）是一家專注於爲患有阻塞性睡眠呼吸暫停的患者開發和商業化創新微創解決方案的醫療科技公司，今天宣佈其管理團隊將於2025年1月13日（星期一）在第43屆摩根大通醫療健康大會上進行演講。
Inspire is scheduled to present at 11:15 a.m. Eastern Time. The presentation will be accessible via a live webcast here.
Inspire定於東部時間上午11:15進行演講。您可以通過此處的直播網絡廣播訪問演講。
Webcast replays of the presentations will be available for two weeks following the presentations in the Event Archive section of Inspire's Investor website at .
演講的網絡廣播重播將在演講後兩週內在Inspire的投資者網站的活動存檔部分提供。
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire's proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology of its kind that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
關於inspire 醫療系統
Inspire是一家專注於爲患有阻塞性睡眠呼吸暫停的患者開發和商業化創新微創解決方案的醫療科技公司。Inspire專有的Inspire療法是首個也是唯一一個獲得FDA、歐盟醫療器械法規（EU MDR）和藥品市場管理局（PDMA）批准的神經刺激技術，提供安全有效的中度至重度阻塞性睡眠呼吸暫停的治療。
For additional information about Inspire, please visit .
有關Inspire的更多信息，請訪問。
Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443
投資者和媒體聯繫方式
Ezgi Yagci
副總裁，投資者關係
ezgiyagci@inspiresleep.com
617-549-2443
